Menopause Webinar 2023
Topics
Meeting category
Date(s)
23 Jan 2025
Program Language
English
Meeting type
Virtual Meeting

2nd Menopause & HIV Webinar 2025

General
What's New
  • The 2nd Menopause & HIV Webinar will take place on Thursday, 23 January 2025 at 16:00 - 17:00 CET.
  • To stay updated on the relevant developments, make sure you are signed up for our newsletter.

About this Webinar

Menopause is a transition phase in aging women that is associated with hormonal changes that increase the risk for cardiovascular, bone, and neurocognitive diseases. Women in menopause are also at higher risk of acquiring  HIV. However, little is known about the relationship between HIV and menopause.

Women living with HIV enter menopause 3-5 years earlier than those living without the virus. They experience more severe symptoms and show a higher risk for co-morbidities compared to women living without HIV. Severe menopausal symptoms have been associated with reduced quality of life, poorer mental health, and reduced adherence to HIV care.

Overall, monitoring and clinical management of menopause-related comorbidities and symptoms in women living with HIV becomes burdensome when there are limited official guidelines.  

To meet this need, this program will gather a diverse audience of researchers, healthcare professionals, pharmacologists, regulatory, and community representatives to increase awareness about the interplay of HIV and menopause. A dialogue will be stimulated with the aim of improving the management of symptoms, co-morbidities, and quality of life in women who experience menopause and are living with HIV.

Program Chair
General Information 
Who Should Attend?
- Clinicians focusing on HIV

- Researchers

- General practitioners

- Gynaecologists

- Pharmacologists

- Regulatory representatives

- Patient community representatives

- Industry representatives
Meeting Objectives
This meeting aims to:

• Increase awareness on challenges faced by women living with HIV and experiencing menopause;

• Stimulate discussion among participants of different backgrounds on appropriate management of conditions that appear in women living with HIV and experiencing menopause.
Learning Objectives
After participating in this activity, participants will be able to:

• Summarize symptoms and other challenges faced by women living with HIV and experiencing menopause;

• Outline latest data on treatment regimens and pharmacological characteristics;

• Reflect on strategies to manage menopausal symptoms in women living with HIV.
Practical Information 
Certificate of Attendance
A digital certificate of attendance will be sent to you after successfully completing the program and post-webinar survey.
Language
The official language of the webinar is English

Translation will not be provided.
Enduring Materials
Provided the Speakers' Permission, video recordings and presentation slides will be available shortly after the completion of the webinar.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration
Registration is Open!
Fees and Conditions

Regular Delegates 

Industry Delegates
Registration Fee Complimentary €195

The following falls under the ''regular delegates'' category: clinicians, researchers, general practitioners, gynaecologists, pharmacologists, regulatory representatives, patient community representatives.

Important
  • We strongly advise that you register early to ensure your registration. 

  • Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.

Registration Fee Includes
- Access to all scientific sessions

- Digital workshop pack, including the program.


IMPORTANT:

- Payment can only be made by credit card.

- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
Payment
By credit card only: online or by written authorization (see online registration).
Cancellation Policy
In case of cancellation, the following refunds are applicable:

- Cancellation before/on 30 December 2024: 50% refund (minus an administration fee of €40)

- Cancellation after 30 December 2024: Unfortunately, no refund will be given

If you are unable to attend the webinar, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the secretariat has been notified of the name of the substitute delegate before 12 January 2025. A statement (email/letter) of cancellation must be sent to Virology Education.
Liability and Insurance
By registering for the webinar, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Disclaimer
This webinar is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this webinar, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this webinar. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the webinar. In case of cancellation of the webinar due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
Program
Preliminary Program
2nd Menopause & HIV Webinar 2025 - 16:00
16:00 CET
Opening of the Webinar
Karoline Aebi-Popp, PD, MD, MSc
University Hospital Bern, Switzerland
16:05 CET
How to Support Women Living with HIV during Transition to Menopause
16:25 CET
Co-morbidities Screening and Prevention for Women After Menopause
16:45 CET
Discussion
16:55 CET
Closure of the Webinar
Karoline Aebi-Popp, PD, MD, MSc
University Hospital Bern, Switzerland
Support
Support
ViiV

    

The 2nd Menopause & HIV Webinar 2025 is supported by an independent educational grant from ViiV Healthcare.

ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

Previous Editions